Benign Prostatic Hyperplasia Diagnosis
Benign Prostatic Hyperplasia Diagnosis
The assessment of an enlarged prostate is one of the more satisfactory consultations in urology, because it answers its questions with cheap and painless tests. How much do the symptoms bother you is answered by a seven-question score. Is there anything here that is not BPH is answered by a rectal examination and a PSA blood test. Is the obstruction significant, and has it already affected the bladder or kidneys is answered by an ultrasound that measures the gland and the urine left behind after voiding, a flow study, a urinalysis and a creatinine. Read together, those four answers place a patient on the ladder — watch, treat, or relieve — and give a baseline against which any future treatment can honestly be judged. The last point is worth stating plainly: a diagnosis that produces only a label has not finished the job. What should come out of the consultation is a plan, and the numbers that will be used to check it.
The symptom score: turning an experience into a number
The International Prostate Symptom Score asks seven questions and one more about how the patient feels about his situation:
- The seven symptoms — how often the bladder feels incompletely emptied, how often urination must be repeated within two hours, how often the stream stops and starts, how difficult it is to postpone urination, how weak the stream is, how much straining is needed, and how many times the patient gets up at night.
- The scale — each question is scored from 0 to 5, giving a total between 0 and 35: 0–7 is usually mild, 8–19 moderate, and 20–35 severe.
- The quality-of-life question — how the patient would feel if his urinary condition stayed exactly as it is now. This single question often decides the treatment: two men with identical scores can answer it very differently, and the one who is untroubled is entitled to be managed differently.
- Why the number matters — it makes symptoms comparable over time and gives medication or surgery a baseline. Improvement is then measured, rather than remembered.
Rectal examination and PSA: answering the cancer question
These two steps exist in the assessment of an enlarged prostate for one principal reason: to establish that the enlargement is in fact benign.
- Digital rectal examination — the prostate is felt through the rectal wall for size, consistency, symmetry and any hard nodule. A benign gland is typically smooth and rubbery; hardness, asymmetry or a nodule changes the plan entirely and moves the assessment towards imaging and, if indicated, biopsy.
- PSA — prostate-specific antigen is a blood test that is raised by an enlarged prostate, by inflammation and by prostate cancer. It is not a cancer test on its own, and it is not a substitute for the examination; it is interpreted alongside the size of the gland and how it feels.
- The common misunderstanding — a raised PSA in a man with obvious enlargement is not automatically reassuring. A large benign gland explains a moderately raised value, but that explanation has to be judged against the examination and, where needed, imaging, rather than being assumed.
- What to expect — a repeat test where the value is borderline, imaging of the prostate where it is clearly raised or the examination is abnormal, and a biopsy only when the combined picture calls for it.
Ultrasound: the size of the gland and the urine left behind
This single painless test produces two of the most decision-changing numbers in the whole assessment:
- Prostate volume — measured in millilitres, and used to choose medication: a relaxant tablet helps whatever the size, while the shrinking agents are generally reserved for larger glands, since the smaller ones have less tissue to reduce.
- Post-void residual urine — the volume left in the bladder immediately after the patient has voided. It is the number that reveals silent decompensation, and a large residual can move a patient to treatment even when the symptom score is modest.
- The upper urinary tract — the same examination looks at the kidneys and ureters for the swelling that long-standing obstruction can produce, which is the back-pressure that eventually damages kidney function.
- What it cannot tell you — the size of the prostate correlates poorly with how much obstruction there is. A small gland with a prominent muscular component can obstruct severely, and a large gland may be relatively innocent. Volume guides treatment; it does not define the disease.
Uroflowmetry: recording what the stream actually does
A flow study is the objective counterpart to everything the patient has described:
- What happens — the patient arrives with a comfortably full bladder and urinates into a machine, which plots flow against time. The peak flow rate is the headline number, supported by the shape of the curve.
- What a normal result looks like — a rapid rise to a good peak and a smooth fall, in a man who cannot hold on. A flat and prolonged curve suggests obstruction.
- Its limitations, stated honestly — the result depends on how much urine was in the bladder and on effort, so an unrepresentative study should be repeated rather than acted upon. A low flow rate does not by itself prove that the prostate is the cause; a weak bladder muscle produces the same tracing.
- Where it earns its place — before surgery. Having an objective record of obstruction means that the operation is being offered for a measured problem, and that the post-operative result can be compared with something.
Urine, kidney function, and the tests reserved for unclear cases
The remaining tests are unglamorous and occasionally decisive:
- Urinalysis and culture — to find infection, blood or glucose, and to ensure that symptoms are not being attributed to the prostate when an infection is present. Infection also changes the timing of any surgery.
- Creatinine and kidney function — a rising creatinine is one of the strongest signals that an obstruction has been present long enough to matter, and it makes the case for relieving it a medical one rather than a matter of preference.
- Urodynamics — pressure-flow studies, reserved for patients whose picture is unclear: a weak stream with a normal prostate, a suspected bladder that does not contract, or symptoms that persist after an operation.
- Cystoscopy — direct inspection of the urethra and bladder, usually when surgery is being planned, when a stricture or a bladder stone is suspected, or when blood in the urine needs its own explanation.
What the assessment should produce
The outcome of a complete assessment is not a label but four decisions:
- Whether this can be watched — and if so, which numbers will be repeated, and when, to demonstrate that watching remains safe.
- Whether medication is worth starting — and with which agent, given the size of the gland and whether the symptoms are mainly voiding or mainly storage.
- Whether the obstruction should be relieved — on symptoms that have not responded, on patient preference after a fair explanation, or on a complication such as retention, infection, stones, blood or back-pressure on the kidneys.
- What the cancer question requires — whether the PSA and examination need repeat testing, imaging or no further action for now.
Where a patient is travelling for assessment, those four decisions are exactly what a written second opinion should contain — together with the measurements they rest on, so that nothing has to be taken on trust.